TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpeechMemory, DelayedSensorineural Hearing Loss

Effects of Clear Speech on Listening Effort and Memory in Sentence Processing

Eligible age

60–90 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Sensorineural hearing loss (SNHL) is among the most prevalent chronic conditions in aging and has a profoundly negative effect on speech comprehension, leading to increased social isolation, reduced quality of life, and increased risk for the development of dementia in older adulthood. Typical audiological tests and interventions, which focus on measuring and restoring audibility, do not explain the full range of cognitive difficulties that adults with hearing loss experience in speech comprehension. For example, adults with SNHL have to work disproportionally harder to decode acoustically degraded speech. That additional effort is thought to diminish shared executive and attentional resources for higher-level language processes, impacting subsequent comprehension and memory, even when speech is completely intelligible. This phenomenon has been referred to as listening effort (LE). There is a growing understanding that these cognitive factors are a critical and often "hidden effect" of hearing loss. At the same time, the effects of LE on the neural mechanisms of language processing and memory in SNHL are currently not well understood. In order to develop evidence-based assessments and interventions to improve comprehension and memory in SNHL, it is critical that the cognitive and neural mechanisms of LE and its consequences for speech comprehension are elucidated. In this project, the investigators adopt a multi-method approach, combining methods from clinical audiology, psycholinguistics, and cognitive neuroscience to address this gap of knowledge. Specifically, the investigators adopt a novel and innovative method of co-registering pupillometry (a reliable physiological measure of LE) and language-related event-related brain potential (ERP) measures during real-time speech processing to characterize the effects of clear speech (i.e., a listener-oriented speaking style that is spontaneously adopted to improve intelligibility when speakers are aware of a perception difficulty on behalf of the listener) on high-level language processes (e.g., semantic retrieval, syntactic integration) and subsequent speech memory in older adults with SNHL. This innovative work addresses a time-sensitive gap in the literature regarding the identification of objective and reliable markers of specific neurocognitive processes impacted by speech clarity and LE in age-related SNHL.

Sponsor: University of Utah

You may qualify if…

  • ✓ Age 60-90
  • ✓ Right-handed
  • ✓ Native English speaker
  • ✓ Scores in the normal range (\> or = 25 points) on Montreal Cognitive Assessment (MoCA)
  • ✓ For adults with hearing loss, a pure-tone average score of \> 25 dB HL (between 1 - 4kHz)

You may not qualify if…

  • ✕ Left-handed (language-related electrophysiological responses of left-handed subjects differ from those of right-handed subjects)
  • ✕ History of psychiatric or neurological illnesses (including skull fractures, as this is known to alter electrophysiological response at the scalp)
  • ✕ Score of \< 25 points on the MOCA
  • ✕ Use of certain prescription and non-prescription drugs known to alter brain function and the autonomic nervous system, including pupil dilation (e.g., anti-depressants, attention deficit hyperactivity disorder drugs)
  • ✕ Any eye disease that would impair the ability to measure pupil dilation (e.g., cataracts, nystagmus, amblyopia)
  • ✕ Scores on speech shadowing audibility control task below 50%, suggesting poor intelligibility
  • ✕ A display of behavior that would significantly interfere with the validity of data collection or safety during the study;

Where it's recruiting

Utah

Salt Lake City

Source: ClinicalTrials.gov · NCT06053190 · last updated 2025-01-13